Introduction Hetero Labs is a company that produces and distributes active pharmaceutical components. The company's offerings include antihypertensive drugs such as amlodipine besylate, doxazosin mesylate, benazepril, irbesartan, acitretin, adefovir dipivoxil, and alfuzosin HCL. Hetero Labs was established on March 10, 1989 and is based in Hyderabad, India. |
Disease Domain | Count |
---|---|
Infectious Diseases | 2 |
Endocrinology and Metabolic Disease | 1 |
Neoplasms | 1 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 2 |
Top 5 Target | Count |
---|---|
RdRp(RNA-directed RNA polymerase) | 1 |
Proton pump(Proton pump) | 1 |
Target |
Mechanism RdRp inhibitors [+1] |
Active Org. |
Originator Org. |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. GB |
First Approval Date14 Nov 2021 |
Target |
Mechanism Proton pump inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. DE |
First Approval Date01 Jan 1994 |
Start Date30 Nov 2023 |
Sponsor / Collaborator |
Start Date28 Feb 2023 |
Sponsor / Collaborator |
Start Date30 May 2022 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Molnupiravir ( RdRp ) | COVID-19 More | Approved |
Pantoprazole Sodium Hydrate ( Proton pump ) | Peptic Ulcer More | NDA/BLA |